
CNS Pharmaceuticals CNSP
€ 4.05
6.22%
Land |
|
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
443 K |
Marktkapitalisierung |
$ 1.97 M |
EBITDA (LTM) |
$ -16.3 M |
P/E (LTM) |
-0.18539 |
P/S (LTM) |
- |
EPS (LTM) |
-18.07 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | ||
|
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | ||
|
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | ||
|
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | ||
|
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | ||
|
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | ||
|
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | ||
|
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | ||
|
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | ||
|
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | ||
|
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | ||
|
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | ||
|
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | ||
|
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | ||
|
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | ||
|
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | ||
|
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | ||
|
Keros Therapeutics
KROS
|
$ 12.0 | 6.1 % | $ 447 M | Nasdaq Global Select Market | ||
|
Фармсинтез
LIFE
|
- | - | - | MOEX | ||
|
Atara Biotherapeutics
ATRA
|
$ 6.85 | 5.38 % | $ 85.9 M | Nasdaq Global Select Market,SPB | ||
|
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | ||
|
Actinium Pharmaceuticals
ATNM
|
$ 1.09 | -19.26 % | $ 34 M | NYSE American | ||
|
Axon Enterprise
AXON
|
$ 300.63 | 0.68 % | $ 23.5 B | Nasdaq Global Select Market,SPB | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
MannKind Corporation
MNKD
|
$ 4.08 | 0.12 % | $ 1.25 B | Nasdaq Global Market | ||
|
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | ||
|
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | ||
|
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | ||
|
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | ||
|
PhaseBio Pharmaceuticals
PHAS
|
- | 7.4 % | $ 6.29 M | Nasdaq Global Market | ||
|
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | ||
|
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market | ||
|
Can-Fite BioPharma Ltd.
CANF
|
$ 1.48 | -3.27 % | $ 2.44 M | NYSE American | ||
|
Provention Bio
PRVB
|
- | - | $ 2.37 B | Nasdaq Global Select Market | ||
|
Reata Pharmaceuticals
RETA
|
- | - | $ 6.29 B | Nasdaq Global Market,SPB | ||
|
Rhythm Pharmaceuticals
RYTM
|
$ 119.1 | 2.14 % | $ 7.74 B | Nasdaq Global Market,SPB | ||
|
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
$ 2.76 | -8.35 % | $ 36.8 M | Nasdaq Global Market | ||
|
PolarityTE
PTE
|
- | -0.82 % | $ 1.78 M | Nasdaq Capital Market | ||
|
Kronos Bio
KRON
|
- | 1.49 % | $ 50.8 M | Nasdaq Global Select Market | ||
|
Cullinan Management
CGEM
|
$ 9.01 | -2.86 % | $ 543 M | Nasdaq Global Select Market | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
$ 54.13 | 2.46 % | $ 151 M | Nasdaq Global Select Market | ||
|
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | ||
|
Trevena
TRVN
|
- | -46.58 % | $ 31.8 M | Nasdaq Capital Market | ||
|
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | ||
|
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | ||
|
Oncorus
ONCR
|
- | -8.54 % | $ 3.19 M | Nasdaq Global Market | ||
|
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB |